{
  "created_at": "Tue Nov 09 16:40:13 +0000 2021",
  "id_str": "1458098592510582784",
  "full_text": "Interim trial results found that patients with a risk factor for covid-19 were 50% less likely to be hospitalised or die if the oral antiviral was taken in the first five days after symptoms https://t.co/D6rHvONqY5",
  "display_text_range": [
    0,
    214
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/D6rHvONqY5",
        "expanded_url": "https://econ.st/2YntsIA",
        "display_url": "econ.st/2YntsIA",
        "indices": [
          191,
          214
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 32,
  "favorite_count": 107,
  "possibly_sensitive": false,
  "original_created_at": "Tue Nov 09 15:46:09 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "中間試験の結果では、コヴィド-19の危険因子を持つ患者が、症状が出てから最初の5日間に経口抗ウイルス剤を服用した場合、入院や死亡の可能性が50％低くなることがわかりました。https://t.co/D6rHvONqY5"
    },
    {
      "locale": "zh",
      "full_text": "临时试验结果发现，具有covid-19风险因素的患者，如果在症状出现后的头五天内口服抗病毒药物，住院或死亡的可能性降低50% https://t.co/D6rHvONqY5。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "臨時試驗結果發現，具有covid-19風險因素的患者，如果在症狀出現後的頭五天內口服抗病毒藥物，住院或死亡的可能性降低50% https://t.co/D6rHvONqY5。"
    }
  ]
}